IQVIA HOLDINGS INC. Unrealized Loss on Foreign Currency Derivatives, before Tax
IQVIA HOLDINGS INC. (IQV) reported Unrealized Loss on Foreign Currency Derivatives, before Tax of $1.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments by Risk Exposure
us-gaap:UnrealizedLossOnForeignCurrencyDerivativesBeforeTax · last filed 2018-02-16
- IQVIA HOLDINGS INC. unrealized loss on foreign currency derivatives, before tax for fiscal 2017 was $1.00M.
| Period end | Unrealized Loss on Foreign Currency Derivatives, before Tax 12 month |
|---|---|
| 2017-12-31 | $1.00M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |